Share

Prof Saul Faust, who led the trial at University Hospital Southampton NHS Foundation Trust, said: “It’s really encouraging that a wide range of vaccines, using different technologies, show benefits as a third dose to either AstraZeneca or Pfizer-BioNTech.

Source: BBC

Leave a Reply

Your email address will not be published.

WP Radio
WP Radio
OFFLINE LIVE